Division of Ethnopharmacology, Entomology Research Institute, Loyola College, Chennai, Tamilnadu 600 034, India.
Pharm Biol. 2012 Jun;50(6):698-706. doi: 10.3109/13880209.2011.618993. Epub 2011 Dec 1.
Enicostema axillare A. Raynal (Gentianaceae) has been used in the traditional Indian system of medicine as a depurative and for the treatment of skin diseases, tumors, intermittent fever, and helminthiasis.
E. axillare was investigated for antimutagenic and antioxidant effects.
The antioxidant and antimutagenic activities of E. axillare fractions were determined by 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging assay and Ames test using Salmonella typhimurium tester strains TA98 and TA100 against direct-acting mutagens, such as sodium azide (NaN₃), 4-nitro-O-phenylene diamine (NPD), and mutagen needing activation, such as 2-aminofluorene (2AF). Toxicity study of these fractions was also performed.
The ethyl acetate fraction showed maximum antimutagenic effect by 88.25 and 84.46% (preincubation) and 85.13 and 84.47% (coincubation) of inhibition against NaN₃ and NPD-induced mutagenicity, respectively. Inhibition of S9-dependent mutagens such as 2AF was higher than direct-acting mutagens by the ethyl acetate fraction of E. axillare. It showed 90.25 and 92.00% of inhibition in the preincubation and coincubation experiments. The ethyl acetate fraction showed higher total antioxidant capacity (24.79 ± 0.29 µg) and low IC₅₀ value for DPPH radical scavenging assay (192.27 ± 3.67 µg). The overall effect of E. axillare fractions was found to be in the order: ethyl acetate > methanol > hexane in these assays. In subacute toxicity study, with oral administration of these fractions, no marked biochemical and histopathologic changes were observed.
The significant antimutagenic and antioxidant activities of E. axillare might provide a scientific validation for the traditional use of this plant.
肾叶鹿药(龙胆科)在印度传统医学中被用作净化剂,用于治疗皮肤病、肿瘤、间歇性发热和寄生虫病。
研究肾叶鹿药的抗诱变和抗氧化作用。
采用 2,2-二苯基-1-苦基肼(DPPH)自由基清除法和鼠伤寒沙门氏菌 TA98 和 TA100 测试菌株的艾姆斯试验,测定肾叶鹿药各部位的抗氧化和抗诱变活性,对抗直接致突变剂,如叠氮化钠(NaN₃)、4-硝基-O-苯二胺(NPD),以及需要激活的诱变剂,如 2-氨基芴(2AF)。还对这些部位进行了毒性研究。
乙酸乙酯部位对NaN₃和NPD 诱导的致突变性的抑制率分别为 88.25%和 84.46%(预孵育)和 85.13%和 84.47%(共孵育),显示出最大的抗诱变作用。肾叶鹿药乙酸乙酯部位对 S9 依赖性致突变物如 2AF 的抑制作用高于直接致突变物,预孵育和共孵育试验的抑制率分别为 90.25%和 92.00%。乙酸乙酯部位的总抗氧化能力较高(24.79±0.29µg),DPPH 自由基清除试验的 IC₅₀ 值较低(192.27±3.67µg)。在这些试验中,肾叶鹿药各部位的综合作用顺序为:乙酸乙酯>甲醇>正己烷。在亚急性毒性研究中,这些部位经口服给药,未观察到明显的生化和组织病理学变化。
肾叶鹿药具有显著的抗诱变和抗氧化活性,为该植物的传统应用提供了科学依据。